The development status and analysis of Traditional Chinese Medicine in USA

VernacularTitle:中医药在美国的发展现状与分析
Author: Sijing DU ; Siyuan ZHOU ; Ning LIANG ; Haoyue LI ; Jing ZHAO ; Kakit HUI ; Hongxin CAO
From: International Journal of Traditional Chinese Medicine 2021;43(5):422-428
CountryChina
Language:Chinese
Abstract: American medical insurance is mainly composed of public medical insurance borne by the government and private medical insurance. The main cause of death in this country are ischemic heart disease, Alzheimer’s disease, and lung cancer. The motality rate mainly caused by drug use disorders, chronic kidney disease and Alzheimer’s disease. The development of Chinese herbal medicine is relatively slow and difficult. The education system has covered Traditional Chinese Medicine (TCM). However, there still exist certain challenges of the development of TCM acupuncture faces the challenge of localization; Chinese herbal medicine still lacks standardization and TCM education needs to be standardized. Based on the current situation, it is suggested to focus on the development of acupuncture and moxibustion, to promote the registration and declaration of Chinese herbal medicine products for treating difficult diseases, and to strengthen the international exchange of TCM education, so as to promote the development and spread of TCM in the United States.